[HTML][HTML] Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
The recent emergence of the SARS-CoV-2 Omicron variant is raising concerns because of
its increased transmissibility and its numerous spike mutations, which have the potential to …
its increased transmissibility and its numerous spike mutations, which have the potential to …
The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 …
…, A Abdel‐Wahed, M Berbic, V Brache… - … of Gynecology & …, 2018 - Wiley Online Library
Background The International Federation of Gynecology and Obstetrics (FIGO) systems for
nomenclature of symptoms of normal and abnormal uterine bleeding (AUB) in the …
nomenclature of symptoms of normal and abnormal uterine bleeding (AUB) in the …
Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS
…, S El Mahgoub, S Diaz, M Pavez, F Alvarez, V Brache… - Contraception, 1991 - Elsevier
A levonorgestrel-releasing IUD and the Copper T 380Ag IUD were in randomized comparison
for seven years in five clinics. In two other clinics the randomized study was truncated at …
for seven years in five clinics. In two other clinics the randomized study was truncated at …
Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture
V Brache, L Cochon, C Jesam… - Human …, 2010 - academic.oup.com
BACKGROUND Current methods of hormonal emergency contraception (EC) are ineffective
in preventing follicular rupture when administered in the advanced pre-ovulatory phase. …
in preventing follicular rupture when administered in the advanced pre-ovulatory phase. …
New insights on the mode of action of intrauterine contraceptive devices in women
F Alvarez, V Brache, E Fernandez, B Guerrero… - Fertility and sterility, 1988 - Elsevier
To gain a better understanding of the mechanism of action of intrauterine devices (IUDs), a
search was made for ova in the genital tracts of 115 women using no contraception and of 56 …
search was made for ova in the genital tracts of 115 women using no contraception and of 56 …
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study
…, DR Mishell Jr, D Shoupe, F Alvarez, V Brache… - Contraception, 1990 - Elsevier
An intrauterine device, releasing approximately 20 μg/day of levonorgestrel (LNg 20), used
by 1124 women, was studied in a randomized trial of five years duration in comparison with …
by 1124 women, was studied in a randomized trial of five years duration in comparison with …
A 3-year multicentre randomized controlled trial of etonogestrel-and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper …
L Bahamondes, V Brache, O Meirik, M Ali… - Human …, 2015 - academic.oup.com
STUDY QUESTION Is there any difference in the clinical performance of the 3-year one-rod
etonogestrel (ENG)- and the 5-year two-rod levonorgestrel (LNG)-releasing contraceptive …
etonogestrel (ENG)- and the 5-year two-rod levonorgestrel (LNG)-releasing contraceptive …
Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens
V Brache, L Cochon, M Deniaud, HB Croxatto - Contraception, 2013 - Elsevier
Background The days just prior to ovulation are the most crucial for emergency contraception
(EC) efficacy. Ulipristal acetate (UPA) and levonorgestrel's (LNG) capacity to inhibit …
(EC) efficacy. Ulipristal acetate (UPA) and levonorgestrel's (LNG) capacity to inhibit …
Contraceptive vaginal rings: a review
V Brache, A Faundes - Contraception, 2010 - Elsevier
Development efforts on contraceptive vaginal rings were initiated over 40 years ago based
on two principles: the capacity of the vaginal epithelium to absorb steroids and the capacity of …
on two principles: the capacity of the vaginal epithelium to absorb steroids and the capacity of …
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
STUDY QUESTION Is it possible to extend the use of the 3-year one-rod etonogestrel (ENG)-releasing
subdermal contraceptive implant to 5 years? SUMMARY ANSWER The extended …
subdermal contraceptive implant to 5 years? SUMMARY ANSWER The extended …
